Evolent Health to Acquire Valence Health, Extending Breadth and Depth of Value-Based Care Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Leerink Partners Remains Bullish on Evolent Health (EVH) Following Investor Call
July 13, 2016 1:31 PM EDTLeerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with investors. On the call management highlighted that they would expect Valence to continue to grow in the ~30% range in 2017. Management also believes that their... More
FBR Capital Raises Price Target on Evolent Health (EVH) to $24 Following Valence Health Acquisitions
July 13, 2016 11:16 AM EDTFBR Capital reiterated an Outperform rating on Evolent Health (NYSE: EVH), and raised the price target to $24.00 (from $16.00), following the company's announced acquisition of most of the assets of Valence Health. In addition to bringing new expertise, EVH will benefit from using Valent for... More
